The Novel SSTR3 Full Agonist ITF2984 Shows Antitumor Properties against Pancreatic Neuroendocrine Tumors. - Bistika M; Marangelo A; Ascione F; Valentini N; Fedeli F; Schrader J; Modena D; Steinkühler C; Pellegata NS (Neuroendocrinology, 2025)